112 related articles for article (PubMed ID: 1706917)
1. Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour.
Markwardt F; Richter M; Walsmann P; Riesener G; Paintz M
Biomed Biochim Acta; 1990; 49(10):1103-8. PubMed ID: 1706917
[TBL] [Abstract][Full Text] [Related]
2. Experimental studies on a recombinant hirudin, CGP 39393.
Gray E; Watton J; Cesmeli S; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1991 Apr; 65(4):355-9. PubMed ID: 2057916
[TBL] [Abstract][Full Text] [Related]
3. Hirudin in disseminated intravascular coagulation.
Nowak G; Markwardt F
Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
[TBL] [Abstract][Full Text] [Related]
4. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
Liebe V; Brückmann M; Fischer KG; Haase KK; Borggrefe M; Huhle G
Semin Thromb Hemost; 2002 Oct; 28(5):483-90. PubMed ID: 12420244
[TBL] [Abstract][Full Text] [Related]
5. Hirudin in renal insufficiency.
Fischer KG
Semin Thromb Hemost; 2002 Oct; 28(5):467-82. PubMed ID: 12420243
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.
Sarembock IJ; Gertz SD; Gimple LW; Owen RM; Powers ER; Roberts WC
Circulation; 1991 Jul; 84(1):232-43. PubMed ID: 1829399
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
8. Haemostyptic effects of batroxobin with regard to hirudin treatment.
Markwardt F; Kaiser B; Richter M
Thromb Res; 1992 Dec; 68(6):475-82. PubMed ID: 1341058
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological survey of recombinant hirudin.
Markwardt F; Fink G; Kaiser B; Klöcking HP; Nowak G; Richter M; Stürzebecher J
Pharmazie; 1988 Mar; 43(3):202-7. PubMed ID: 3380865
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies on the antithrombotic action of hirudin in experimental animals.
Markwardt F; Hauptmann J; Nowak G; Klessen C; Walsmann P
Thromb Haemost; 1982 Jun; 47(3):226-9. PubMed ID: 7112494
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic and haemorrhagic effects of the naturally occurring thrombin inhibitor hirudin.
Kaiser B; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):41-6. PubMed ID: 2459030
[TBL] [Abstract][Full Text] [Related]
12. Displacement of fibrin-bound thrombin by r-hirudin precludes the use of 131I-r-hirudin for detecting pulmonary emboli in the rabbit.
Rubens FD; Ross-Ouellet B; Dennie C; Coates G; Kinlough-Rathbone RL; Hatton MW
Thromb Haemost; 1994 Aug; 72(2):232-8. PubMed ID: 7831658
[TBL] [Abstract][Full Text] [Related]
13. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
Lindhout T; Blezer R; Hemker HC
Thromb Haemost; 1990 Nov; 64(3):464-8. PubMed ID: 2096492
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic studies with recombinant hirudin in dogs.
Nowak G; Markwardt F; Fink E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):70-4. PubMed ID: 2459035
[TBL] [Abstract][Full Text] [Related]
15. A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation time.
Schenk JF; Glusa E; Radziwon P; Butti A; Markwardt F; Breddin HK
Haemostasis; 1996; 26(4):187-94. PubMed ID: 8872129
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin effects of native and recombinant hirudins.
Markwardt F; Stürzebecher J; Glusa E
Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
[TBL] [Abstract][Full Text] [Related]
17. [Profibrinolytic activity of recombinant hirudin?].
Tsakiris DA; Meyer D; Fabbri J; Close P; Marbet GA
Schweiz Med Wochenschr; 1991 Mar; 121(10):338-40. PubMed ID: 2028237
[TBL] [Abstract][Full Text] [Related]
18. [The pharmacokinetics and pharmacodynamics of recombinant hirudin-2 nasal spray].
Zhang YJ; Zhang Q; Hou JL; Wang XL; Chen MX
Yao Xue Xue Bao; 2006 Mar; 41(3):268-71. PubMed ID: 16759001
[TBL] [Abstract][Full Text] [Related]
19. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
[TBL] [Abstract][Full Text] [Related]
20. Physico-chemical properties of recombinant desulphatohirudin.
Electricwala A; Irons L; Wait R; Carr RJ; Ling RJ; Grossenbacher H; Atkinson T
Thromb Haemost; 1990 Jun; 63(3):499-504. PubMed ID: 2402752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
